PARSIPPANY, N.J. / Jul 30, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) will now host its second-quarter 2024 financial results webcast and conference call at 8:00 a.m. (ET) on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements.
Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. There is no change to the webcasting information. A replay of the webcast will be made available on August 6, 2024.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.
| Last Trade: | US$149.69 |
| Daily Change: | 2.93 2.00 |
| Daily Volume: | 676,593 |
| Market Cap: | US$67.530B |
February 14, 2025 February 13, 2025 February 04, 2025 November 04, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
